Welcome to our dedicated page for Allstate SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation (NYSE: ALL) files a range of documents with the U.S. Securities and Exchange Commission, and this page aggregates those SEC filings for ALL with AI-powered summaries. As a public property and casualty insurer, Allstate uses Form 8-K to report material events such as monthly catastrophe loss estimates, Allstate Protection policies in force, quarterly earnings results, dividend declarations and certain governance changes.
Recent Form 8-K filings show Allstate furnishing monthly releases on catastrophe losses and policy counts for auto, homeowners, other personal lines and commercial lines. These exhibits, referenced under Regulation FD, provide detail on estimated catastrophe losses for specific months and tables of policies in force. Other 8-K filings furnish quarterly earnings press releases and investor supplements, giving investors access to the company’s results of operations and financial condition.
Allstate’s filings also list its registered securities under Section 12(b) of the Exchange Act, including common stock (ALL) and several listed instruments such as 5.100% Fixed-to-Floating Rate Subordinated Debentures due 2053 (ALL.PR.B) and depositary shares representing preferred stock series H, I and J. Filings may also disclose board and governance developments, such as changes in lead director roles and director retirements.
On this SEC filings page, users can review Allstate’s Form 8-K disclosures and, where available, other core filings like annual reports on Form 10-K, quarterly reports on Form 10-Q and proxy statements. AI-generated highlights help explain the key points of lengthy documents, making it easier to understand topics such as catastrophe impacts, policy trends, capital structure and corporate actions without reading every page.
Investors interested in ALL SEC filings can use this resource to track new submissions as they appear on EDGAR, quickly scan AI summaries for each filing and drill into the full text when deeper analysis is needed.
A selling stockholder filed a Form 144 to sell up to 33,614 shares of common stock, with an aggregate market value of $6,428,677.5. The notice lists Goldman Sachs & Co. LLC as broker and an approximate sale date of 11/03/2025 on the NYSE.
The seller is identified as the Thomas J. Wilson Revocable Trust dtd 03/13/15. The filing also reports prior sales over the past three months: 16,807 shares on 10/06/2025 for $3,532,582.66 and 16,807 shares on 10/20/2025 for $3,260,884.06.
Context from the notice shows 263,505,334 shares outstanding and indicates portions of the position were originally acquired as compensation via performance awards on 02/22/2018 and 02/08/2019.
Allstate Corp filed a Form 13F reporting its institutional holdings as of the filing period. The report lists 633 portfolio entries with a total market value of $4,381,321,904 and names 2 other included managers.
The filing is signed by Alexandra Band, Senior Vice President & CFO Investment Finance, and identifies the reporting managers as Allstate Investment Management Co and Allstate Investments LLC. This is a routine quarterly holdings disclosure by an institutional manager.
Allstate (ALL) CEO Thomas J. Wilson reported open-market sales totaling 16,807 shares on 10/20/2025 pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025. Tranches executed at weighted-average prices of
After the transactions, he directly owns 195,233.491 Allstate shares. He also reports indirect beneficial holdings, including 111,442 shares by the 2023-B GRAT and 273,954 shares by the 2020 GRAT Remainder Trust.
The Allstate Corporation furnished a Form 8-K under Regulation FD to make available its September 2025 monthly release. The update, posted on allstateinvestors.com and attached as Exhibit 99, announces estimated catastrophe losses and policies in force. The company states the exhibit is furnished and not filed pursuant to Instruction B.2.
This is an informational disclosure intended to provide investors with the latest monthly catastrophe loss estimates and policy counts; specific figures were not included in the excerpt.
Thomas J. Wilson, Chairman, President & CEO of The Allstate Corporation (ALL), reported open-market sales executed under a Rule 10b5-1 trading plan adopted on
After these transactions the reporting person shows 212,040.491 shares held directly and several indirect holdings through trusts and plans totaling 785,718 shares (listed by vehicle). The Form 4 states the sales were effected pursuant to the trading plan and discloses dividend reinvestment activity adding 33.037 shares during April–October 2025.
Mario Rizzo, listed as Chief Operating Officer-AIC of The Allstate Corporation (ALL), reported changes in his beneficial ownership on
Allstate Corporation (ALL) reporting person Jesse E. Merten completed equity transactions tied to long‑term awards and an option exercise in early October 2025. On
Insider award of 7,115 restricted stock units at no cost, vesting in three equal annual installments. An executive officer, Zulfikar Jeevanjee (EVP & CTO - AIC), was granted 7,115 Restricted Stock Units (RSUs) on
Allstate Corporation reported that its Chief Financial Officer, John E. Dugenske, received an award of 4,743 restricted stock units (RSUs) on
Form 144 notice for Allstate Corporation (ALL) reports a proposed sale of 33,614 shares of common stock through Goldman Sachs & Co. LLC on